These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 7254888

  • 1. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
    Haschke F, Wimmer M, Parth K.
    Padiatr Padol; 1981; 16(3):317-26. PubMed ID: 7254888
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The effect of aldosterone antagonists in juvenile heart surgery].
    Wimmer M, Parth K, Holzer H.
    Acta Med Austriaca; 1979; 6(1):8-12. PubMed ID: 506658
    [Abstract] [Full Text] [Related]

  • 4. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F, Remonda G, Morachioli N, Pugnani M.
    Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
    [Abstract] [Full Text] [Related]

  • 5. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 6. [Aldosterone and aldosterone antagonists in surgery].
    Oelert H.
    Anaesthesist; 1971 Jun; 20(6):205-11. PubMed ID: 4943021
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Use of a new water-soluble aldosterone-antagonist in surgery. Early clinical results].
    Nahum M, Ratto GB, Motta G.
    Minerva Med; 1976 Apr 21; 67(19):1263-75. PubMed ID: 934482
    [Abstract] [Full Text] [Related]

  • 9. A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog.
    Guyonnet J, Elliott J, Kaltsatos V.
    J Vet Pharmacol Ther; 2010 Jun 01; 33(3):260-7. PubMed ID: 20557443
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease.
    Alvarez Kindelan A, Pérez Navero JL, Ibarra de la Rosa I, Concha Ruiz M, Montilla López P, Romanos Lezcano A.
    Crit Care Med; 1994 Nov 01; 22(11):1754-61. PubMed ID: 7956278
    [Abstract] [Full Text] [Related]

  • 12. [Plasma aldosterone and electrolytes in primary and secondard aldosteronism (author's transl)].
    Albert JP, Wronski R, Jentzen F, Hartmann F.
    Med Klin; 1979 Sep 14; 74(37):1315-9. PubMed ID: 492054
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Studies on the effect of the aldosterone-antagonist aldadeine-potassium on secondary aldosteronism after surgery with the heart-lung machine].
    Gleichmann U, Bircks W, Bostroem B, Kreuzer H.
    Arzneimittelforschung; 1967 Jun 14; 17(6):741-4. PubMed ID: 5632376
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC, Bräuninger HJ.
    MMW Munch Med Wochenschr; 1975 Sep 14; 117(37):1483-6. PubMed ID: 810673
    [Abstract] [Full Text] [Related]

  • 16. [Primary hyperaldosteronism].
    Plouin PF, Massien-Simon C.
    Rev Prat; 1998 Apr 01; 48(7):749-53. PubMed ID: 11767370
    [Abstract] [Full Text] [Related]

  • 17. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
    Brown JJ, Chinn RH, Dusterdieck G, Fraser R, Lever AF, Robertson JI, Tree M.
    J Endocrinol; 1969 Jan 01; 43(1):iv-v. PubMed ID: 5773780
    [No Abstract] [Full Text] [Related]

  • 18. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
    Brilla CG, Matsubara LS, Weber KT.
    J Mol Cell Cardiol; 1993 May 01; 25(5):563-75. PubMed ID: 8377216
    [Abstract] [Full Text] [Related]

  • 19. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M.
    J Hypertens; 2007 Jan 01; 25(1):177-86. PubMed ID: 17143190
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
    Sharabi Y, Adler E, Shamis A, Nussinovitch N, Markovitz A, Grossman E.
    Am J Hypertens; 2006 Jul 01; 19(7):750-5. PubMed ID: 16814132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.